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Table 2. Number of donor samples that react positively to viral
peptides during screening. A total of 14 donors were screened.
Virus No. of positive donors
Adenovirus (AdV) 6
BK virus (BKV) 1
Cytomegalovirus (CMV) 7
Epstein barr virus (EBV) 0
Human herpesvirus 6 (HHV6) 6
Fig 1. CMV-CIKs are more cytotoxic than CMV-VSTs.
VsCIKs consistently lysed more PHA targets loaded with viral peptides compared to VSTs.
Results shown are from three separate experiments, each comparing CMV-CIKs with CMV-
VSTs generated from the same donor.
Table 3. Comparison of functional activities of vsCIKs and VSTs.
For AdV, VST cells showed greater responses to viral peptides than the vsCIKs. However,
there were incongruities between the cytotoxicity and degranulation comparisons for CMV
and HHV6. So far, no donor cells have shown reactivity against EBV peptides. This is
despite a high percentage of EBV carriers among Singaporeans and the successful use of
the same peptides in published reports.
Virus
vsCIK > VST VST > vsCIK vsCIK  VST
Cytotoxicity Degranulation Cytotoxicity Degranulation Cytotoxicity Degranulation
AdV 0 0 3 4 1 0
BKV 0 0 0 1 1 0
CMV 4 2 0 3 3 2
HHV6 2 0 1 4 2 1
For the comparisons, differences of 10% or more were considered significant, while values
below 5% were considered negative. For cytotoxicity, the values from wells with a ratio of
10:1 (effector:target) were compared.
Reactivation of dormant viruses is not uncommon after allogeneic
haematopoietic stem cell transplants (allo-HSCT). Antiviral drug therapy is
limited by refractory strains and toxicities, while matched donor derived VSTs
have been successfully used to treat allo-HSCT patients with viral reactivation
and there is promising data that minimally matched third party banked VSTs are
also effective and safe. Here we explore the feasibility of a compact and
effective bank of virus-specific cytotoxic cells for allo-HSCT patients.
We (1) reviewed our database of the HLA class I types of 100 consecutive allo-
HSCT recipients, (2) screened the local population for response to viruses of
interest and (3) studied the anti-viral activities of VST and vsCIK cultures to
determine the efficacies of VSTs versus vsCIKs.
Cones, which are normally discarded, from plateletpheresis of healthy donors
were collected with consent. The PBMC in the cones were then screened for
virus reactivity and if positive, further cultured following the vsCIK and VST
protocols.
We showed that our local population share common HLA alleles such that a
compact third party bank from donors with these alleles can cover most
patients. We also successfully generated AdV, BKV, CMV and HHV6-specific
vsCIKs and VSTs. Interestingly, in the comparison between VSTs and vsCIKs for
each virus, the results of the cytotoxicity assays and the degranulation assays
do not always agree. Further screening of viral peptides (particularly for EBV)
and mechanistic studies will be required to determine the more effective cell
type for the proposed bank. We also do not dismiss the possibility that the
more effective anti-viral cell type might be specific for each virus.
Screen for response to viruses
+ viral peptides
overnight
Flow cytometry for activation 
marker, 4-1BB expression
vsCIK Protocol3
+ viral peptides
+ anti-4-1BB
+ IFNγ
+ OKT3
+ IL-2 
VST Protocol2
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1. Cytotoxicity Assay
- Cr51-release assay using autologous PHA blasts with/without peptide loading 
as target cells
2. Degranulation Assay 
- flow cytometry analysis for CD107a expression in response to viral peptides, 
to quantify antigen-specific degranulation 
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INTRODUCTION
Table 1. Presence of common HLA class I alleles in allo-HSCT patients. 
Amongst Singaporeans, 96% carry one or more of the 17 HLA class I alleles that have a
frequency of > 5% in the local population.1 Analysis of the HLA-A, B and C data of 100
consecutive allo-HSCT patients showed that 85% have three or more of these common
alleles, while only 4% do not have any of them. It is, therefore, feasible to establish a
compact panel of cytotoxic cells from donors with these common HLA alleles.
No. of alleles
present
Chinese
(n= 81)
Malay
(n= 10)
Indian
(n= 4)
Others
(n= 5)
Total
(n= 100)
0 0 3 1 0 4
1 1 0 2 1 4
2 5 1 1 0 7
3 20 4 0 2 26
4 21 0 0 1 22
5 20 2 0 0 22
6 14 0 0 1 15
